Current Assets
Available-for-Sale Debt Securities - Amortized Cost
Medtronic Available-for-Sale Debt Securities - Amortized Cost increased by 3.0% to $7.26B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 6.5%, from $6.82B to $7.26B. Over 4 years (FY 2021 to FY 2025), Available-for-Sale Debt Securities - Amortized Cost shows relatively stable performance with a -1.1% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ4 2018
Last reportedQ3 2026Feb 24, 2026
How to read this metric
Changes reflect shifts in the company's liquidity management strategy and the size of its investment portfolio.
Detailed definition
This is the cost basis of debt securities classified as available-for-sale, adjusted for amortization of premiums or dis...
Peer comparison
Standard metric for any corporation holding a significant portfolio of marketable debt securities.
Metric ID:
afs_debt_securities_amortized_costHistorical Data
20 periods
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.14B | $7.50B | $7.74B | $7.80B | $7.13B | $7.03B | $7.09B | $6.98B | $6.75B | $6.89B | $6.80B | $6.91B | $6.97B | $6.69B | $6.71B | $6.82B | $6.83B | $6.91B | $7.05B | $7.26B |
| QoQ Change | — | +4.9% | +3.3% | +0.7% | -8.5% | -1.4% | +0.9% | -1.6% | -3.3% | +2.1% | -1.3% | +1.7% | +0.8% | -4.0% | +0.3% | +1.6% | +0.2% | +1.2% | +1.9% | +3.0% |
| YoY Change | — | — | — | — | -0.2% | -6.2% | -8.4% | -10.5% | -5.4% | -2.0% | -4.2% | -0.9% | +3.3% | -2.9% | -1.3% | -1.4% | -2.0% | +3.3% | +5.0% | +6.5% |
Range$6.69B – $7.80B
CAGR+0.3%
Avg YoY Growth-1.7%
Median YoY Growth-1.7%
Current Streak6 quarters growth
Available-for-Sale Debt Securities - Amortized Cost at Other Companies
Frequently Asked Questions
- What is Medtronic's available-for-sale debt securities - amortized cost?
- Medtronic (MDT) reported available-for-sale debt securities - amortized cost of $7.26B in Q4 2025.
- How has Medtronic's available-for-sale debt securities - amortized cost changed year-over-year?
- Medtronic's available-for-sale debt securities - amortized cost increased by 6.5% year-over-year, from $6.82B to $7.26B.
- What is the long-term trend for Medtronic's available-for-sale debt securities - amortized cost?
- Over 4 years (2021 to 2025), Medtronic's available-for-sale debt securities - amortized cost has grown at a -1.1% compound annual growth rate (CAGR), from $7.14B to $6.83B.
- What does available-for-sale debt securities - amortized cost mean?
- The original purchase price of debt investments adjusted for accounting premiums or discounts.